1. Home
  2. NEO vs LMAT Comparison

NEO vs LMAT Comparison

Compare NEO & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • LMAT
  • Stock Information
  • Founded
  • NEO 2001
  • LMAT 1983
  • Country
  • NEO United States
  • LMAT United States
  • Employees
  • NEO N/A
  • LMAT N/A
  • Industry
  • NEO Precision Instruments
  • LMAT Medical/Dental Instruments
  • Sector
  • NEO Health Care
  • LMAT Health Care
  • Exchange
  • NEO Nasdaq
  • LMAT Nasdaq
  • Market Cap
  • NEO 1.9B
  • LMAT 2.0B
  • IPO Year
  • NEO 1999
  • LMAT 2006
  • Fundamental
  • Price
  • NEO $15.39
  • LMAT $105.87
  • Analyst Decision
  • NEO Strong Buy
  • LMAT Buy
  • Analyst Count
  • NEO 8
  • LMAT 7
  • Target Price
  • NEO $20.25
  • LMAT $92.83
  • AVG Volume (30 Days)
  • NEO 722.4K
  • LMAT 139.9K
  • Earning Date
  • NEO 11-05-2024
  • LMAT 10-31-2024
  • Dividend Yield
  • NEO N/A
  • LMAT 0.60%
  • EPS Growth
  • NEO N/A
  • LMAT 49.21
  • EPS
  • NEO N/A
  • LMAT 1.82
  • Revenue
  • NEO $644,118,000.00
  • LMAT $213,029,000.00
  • Revenue This Year
  • NEO $12.93
  • LMAT $16.04
  • Revenue Next Year
  • NEO $9.70
  • LMAT $9.62
  • P/E Ratio
  • NEO N/A
  • LMAT $58.04
  • Revenue Growth
  • NEO 12.06
  • LMAT 14.81
  • 52 Week Low
  • NEO $12.77
  • LMAT $51.70
  • 52 Week High
  • NEO $21.22
  • LMAT $106.99
  • Technical
  • Relative Strength Index (RSI)
  • NEO 56.48
  • LMAT 70.41
  • Support Level
  • NEO $14.81
  • LMAT $100.45
  • Resistance Level
  • NEO $16.60
  • LMAT $104.82
  • Average True Range (ATR)
  • NEO 0.67
  • LMAT 2.95
  • MACD
  • NEO 0.01
  • LMAT 0.34
  • Stochastic Oscillator
  • NEO 62.77
  • LMAT 91.24

About NEO NeoGenomics Inc.

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

Share on Social Networks: